NASDAQ:OGI - Nasdaq - CA68620P7056 - Common Stock - Currency: USD
OGI earnings call for the period ending December 31, 2024.
Organigram's Q1 FY25 sales hit C$66.8M. Net revenue rose 17%, and adjusted EBITDA improved to C$1.4M. Cash position set to reach C$113M.
Mentions: OGI.CA
Mentions: OGI.CA
Mentions: OGI.CA
OGI earnings call for the period ending September 30, 2024.
Mentions: OGI.CA
Mentions: OGI.CA
Mentions: OGI.CA